Aspire Biopharma Holdings Inc (ASBP) concluded trading on Wednesday at a closing price of $0.71, with 681.55 million shares of worth about $483.9 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -93.71% during that period and on Wednesday the price saw a gain of about 197.43%. Currently the company’s common shares owned by public are about 48.90M shares, out of which, 39.41M shares are available for trading.
Stock saw a price change of 193.97% in past 5 days and over the past one month there was a price change of 55.94%. Year-to-date (YTD), ASBP shares are showing a performance of -93.86% which decreased to -93.52% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.22 but also hit the highest price of $15.80 during that period. The average intraday trading volume for Aspire Biopharma Holdings Inc shares is 732.08K. The stock is currently trading 122.15% above its 20-day simple moving average (SMA20), while that difference is up 52.55% for SMA50 and it goes to -90.93% lower than SMA200. Aspire Biopharma Holdings Inc (NASDAQ: ASBP) currently have 48.90M outstanding shares and institutions hold larger chunk of about 2.90% of that.
The stock has a current market capitalization of $34.99M and its 3Y-monthly beta is at 0.62. It has posted earnings per share of -$1.71 in the same period. It has Quick Ratio of 0.22. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ASBP, volatility over the week remained 53.65% while standing at 26.81% over the month.
